Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 20, 2020 - Issue 8
Submit an article Journal homepage
2,760
Views
12
CrossRef citations to date
0
Altmetric
Letter to the Editor

Status of a real-life cohort of patients with moderate-to-severe plaque psoriasis treated with secukinumab and considerations on the use of biological agents in the Covid-19 era

Marco Galluzzoa Dermatology Unit, Fondazione Policlinico Tor Vergata, Rome, Italy;b Department of Experimental Medicine, University of Rome “Tor Vergata”, Rome, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3424-5175View further author information
ORCID Icon,
Lorenzo Tofania Dermatology Unit, Fondazione Policlinico Tor Vergata, Rome, Italy;c Department of Systems Medicine, University of Rome “Tor Vergata”, Rome, ItalyORCID Iconhttps://orcid.org/0000-0003-1286-9507View further author information
ORCID Icon,
Luca Bianchia Dermatology Unit, Fondazione Policlinico Tor Vergata, Rome, Italy;c Department of Systems Medicine, University of Rome “Tor Vergata”, Rome, ItalyView further author information
&
Marina Talamontia Dermatology Unit, Fondazione Policlinico Tor Vergata, Rome, Italy;c Department of Systems Medicine, University of Rome “Tor Vergata”, Rome, ItalyORCID Iconhttps://orcid.org/0000-0002-3070-4071View further author information
ORCID Icon
Pages 829-830 | Received 28 May 2020, Accepted 03 Jun 2020, Published online: 16 Jun 2020

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Jiajing Lu & Yuling Shi. (2022) A review of disease burden and clinical management for generalized pustular psoriasis in China. Expert Review of Clinical Immunology 18:10, pages 1023-1032.
Read now
Gustavo Gomes Resende, Ricardo da Cruz Lage, Samara Quadros Lobê, Amanda Fonseca Medeiros, Alessandra Dias Costa e Silva, Antônio Tolentino Nogueira Sá, Argenil José de Assis Oliveira, Denise Sousa, Henrique Cerqueira Guimarães, Isabella Coelho Gomes, Renan Pedra Souza, Renato Santana Aguiar, Roberto Tunala, Francisco Forestiero, Julio Silvio Souza Bueno Filho & Mauro Martins Teixeira. (2022) Blockade of interleukin seventeen (IL-17A) with secukinumab in hospitalized COVID-19 patients – the BISHOP study. Infectious Diseases 54:8, pages 591-599.
Read now
Khalaf Kridin, Yochai Schonmann, Arie Solomon, Giovanni Damiani, Dana Tzur Bitan, Erez Onn, Orly Weinstein & Arnon Dov Cohen. (2022) Risk of COVID-19 infection, hospitalization, and mortality in patients with psoriasis treated by interleukin-17 inhibitors. Journal of Dermatological Treatment 33:4, pages 2014-2020.
Read now

Articles from other publishers (9)

Meitong Liu, Huijuan Wang, Lu Liu, Saijin Cui, Xiangran Huo, Zhuoyun Xiao, Yaning Zhao, Bin Wang, Guoqiang Zhang & Na Wang. (2022) Risk of COVID-19 infection, hospitalization and mortality in psoriasis patients treated with interleukin-17 inhibitors: A systematic review and meta-analysis. Frontiers in Immunology 13.
Crossref
Anna Campanati, Federico Diotallevi, Emanuela Martina, Giulia Radi & Annamaria Offidani. (2022) Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities. Journal of Clinical Medicine 11:9, pages 2422.
Crossref
Elham Behrangi, Afsaneh Sadeghzadeh‐Bazargan, Nastaran Salimi, Zoha Shaka, Mohammad Hosein Feyz Kazemi & Azadeh Goodarzi. (2022) Erythrodermic flare‐up of psoriasis with COVID‐19 infection: A report of two cases and a comprehensive review of literature focusing on the mutual effect of psoriasis and COVID‐19 on each other along with the special challenges of the pandemic. Clinical Case Reports 10:4.
Crossref
Huanhuan Zeng, Siyu Wang, Ling Chen & Zhu Shen. (2021) Biologics for Psoriasis During the COVID-19 Pandemic. Frontiers in Medicine 8.
Crossref
Francesco Maione, Gian Marco Casillo, Federica Raucci, Cristian Salvatore, Giovanna Ambrosini, Luisa Costa, Raffaele Scarpa, Francesco Caso & Mariarosaria Bucci. (2021) Interleukin-17A (IL-17A): A silent amplifier of COVID-19. Biomedicine & Pharmacotherapy 142, pages 111980.
Crossref
Scott H Berg, Esther A Balogh, Rima I Ghamrawi & Steven R Feldman. (2021) A review of secukinumab in psoriasis treatment. Immunotherapy 13:3, pages 201-216.
Crossref
E.V. Svechnikova, Z.B. Marshani, K.A. Fomin & E.Yu. Evdokimov. (2021) Genetically engineered biological drugs in psoriasis treatment in the COVID-19 pandemic. Klinicheskaya dermatologiya i venerologiya 20:5, pages 95.
Crossref
Cristina Mugheddu, Silvia Sanna, Laura Atzori & Franco Rongioletti. (2021) Safety of secukinumab treatment in COVID ‐19 affected psoriatic patients . Dermatologic Therapy 34:1.
Crossref
N. N. Potekaev, O. V. Zhukova, S. I. Artemyeva & M. N. Ostretsova. (2020) Experience in managing psoriasis patients receiving targeted therapy during the COVID-19 pandemic. Meditsinskiy sovet = Medical Council:12, pages 10-16.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.